Stanford study validates two effective therapies for childhood eating disorder ARFID

For the first time, researchers have solid evidence about what actually works when a child refuses to eat. Stanford Medicine scientists completed the first rigorous, randomized trial testing treatments for avoidant restrictive food intake disorder—ARFID—a condition that affects between 2 and 6 percent of children and adolescents. The study, published in the Journal of the American Academy of Child & Adolescent Psychiatry, followed 98 children ages 6 to 12 and identified two distinct therapeutic approaches that help expand what these children will eat and improve their overall symptoms.

ARFID is not picky eating, though it often gets mistaken for it. Children with ARFID don't worry about their body shape the way children with anorexia or bulimia do. Instead, they eat too little because of other reasons entirely: they have almost no appetite, they're deeply afraid of certain textures or tastes, or they've had a frightening experience—a choking incident, an allergic reaction—that made them terrified to eat. The condition can emerge at any point in childhood and, left untreated, can derail growth, cause serious nutritional deficiencies like vitamin A depletion or scurvy, and create a kind of social isolation. Kids can't go to summer camp. They don't eat during the school day and come home exhausted. Birthday parties become ordeals.

The Stanford team tested two treatments, each delivered over four months in fourteen one-hour sessions conducted online so families across the country could participate. The first approach, family-based therapy, puts parents in charge. A therapist guides them on how to manage the eating behaviors—the extreme selectivity, the refusal, the fear—while children gradually take on age-appropriate responsibility as they grow. All family members, including siblings, attend sessions together. The therapist helps parents understand that the child is not the disorder. As one of the study's researchers, Brittany Matheson, explained it to younger children: "It's like an alien is coming to your brain." For parents, the message was different but aligned: be firm about not accommodating the eating disorder while remaining loving and compassionate toward the child who is struggling with it.

The second treatment, psychoeducational motivational therapy, takes the opposite approach. It centers the child. In this method, children attend nine sessions with a therapist while parents attend five separate sessions. The therapist helps the child understand what ARFID is and why their parents worry about it—insight a six-year-old often lacks. Then, through play, the therapist figures out what might motivate the child to eat differently. They might design an imaginary restaurant menu together, or research foods from a country the child dreams of visiting. Parents learn about the disorder and how to reduce conflict at mealtimes, supporting changes the child decides to make on their own.

The results diverged in an important way. Children who received family-based therapy gained a statistically significant amount of weight by the end of the study—a clear marker of recovery. Those in the individual treatment did not gain weight at the same rate. Children with more severe ARFID symptoms also responded better to family-based treatment. Yet both approaches significantly improved ARFID symptoms overall. The researchers now have evidence for two different paths forward, each with distinct advantages.

Julia Ceresnak was ten when she enrolled in the study in 2020. She was assigned to the individual therapy track and worked with Matheson to develop strategies for trying new foods. Julia kept lists categorizing foods as "always," "sometimes," and "not yet"—and felt genuine accomplishment watching items move from one category to another. Her parents created a tracking system with stickers; once Julia had tried fifty new foods, she earned a prize: a painting kit. "That was very motivational for me, as a little kid," Julia, now fifteen, recalled. Over time, her motivation shifted. She stopped chasing prizes and started thinking about health and adventure. With Matheson's help, she planned food strategies for camp and school trips to Disneyland and Costa Rica. The foods that once seemed impossible—avocado, eggs, pomegranates, edamame, yogurt with berries—became part of her regular diet. Her mother, Karen, remembered how desperately she had wanted Julia to simply eat eggs. Now Julia says, "I like eggs a lot."

The condition was formally recognized in the Diagnostic and Statistical Manual of Mental Disorders only in 2013, and many children still go undiagnosed because pediatricians dismiss their eating struggles as normal childhood pickiness. But ARFID doesn't resolve on its own. It can cause dangerous vitamin deficiencies, poor growth, short stature, and impaired fertility. It disrupts school performance and social life. What makes ARFID somewhat easier to treat than other eating disorders, according to James Lock, the study's lead author, is that children don't actually want it. They're not defending the restriction. They want help.

Stanford Medicine Children's Health offers outpatient treatment for most ARFID patients, though some require hospitalization with medically supervised refeeding and nutritional support. For the first time, clinicians now have an evidence base for which approach to try first and what to expect. The study was funded by the National Institute of Mental Health.